Delta-Fly Pharma
4598
東証グロース
医薬品
Delta-Fly Pharmaの決算推移
損益計算書
(単位:百万円)
2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | |
---|---|---|---|---|---|---|
売上高 | N/A | 100 | 300 | 300 | N/A | N/A |
売上原価 | N/A | N/A | N/A | N/A | N/A | N/A |
売上総利益 | N/A | N/A | N/A | N/A | N/A | N/A |
販管費 | N/A | N/A | N/A | N/A | N/A | N/A |
営業利益 | -593 | -1,546 | -853 | -962 | -1,316 | -1,404 |
営業外収益 | 0 | 0 | 0 | 0 | 0 | 0 |
営業外費用 | 79 | 7 | 7 | 2 | 9 | 23 |
経常利益 | -672 | -1,553 | -860 | -965 | -1,326 | -1,427 |
特別利益 | N/A | N/A | N/A | N/A | N/A | N/A |
特別損失 | N/A | N/A | N/A | N/A | N/A | N/A |
当期純利益 | -674 | -1,556 | -863 | -968 | -1,329 | -1,430 |
貸借対照表
(単位:百万円)
2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | |
---|---|---|---|---|---|---|
資産 | 3,567 | 2,162 | 2,161 | 1,324 | 906 | 1,474 |
流動資産 | 3,532 | 2,115 | 2,115 | 1,280 | 866 | 1,432 |
現金及び預金 | 3,508 | 1,943 | 2,088 | 1,268 | 844 | 1,417 |
売上債権 | N/A | 110 | N/A | N/A | N/A | N/A |
棚卸資産 | N/A | N/A | N/A | N/A | N/A | N/A |
固定資産 | 35 | 46 | 45 | 43 | 40 | 41 |
負債 | 63 | 105 | 82 | 91 | 115 | 241 |
流動負債 | 56 | 105 | 82 | 91 | 115 | 241 |
仕入債務 | N/A | N/A | N/A | N/A | N/A | N/A |
固定負債 | 6 | N/A | N/A | N/A | N/A | N/A |
純資産 | 3,504 | 2,056 | 2,078 | 1,233 | 791 | 1,232 |
利益剰余金 | -2,067 | -3,623 | -4,485 | -5,452 | -6,781 | -8,211 |
自己株式 | N/A | -1 | -1 | -1 | -1 | -1 |